NCT00156065View on ClinicalTrials.gov

Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785)

PHASE3CompletedINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

October 31, 2007

Conditions
Schizophrenia
Interventions
DRUG

Haloperidol

2-8 mg BID

DRUG

Asenapine

5 or 10 mg BID

DRUG

Asenapine

5 or 10 mg BID

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00156065 - Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785) | Biotech Hunter | Biotech Hunter